GUIDED THERAPEUTICS INC Cash And Cash Equivalents At Carrying Value

Quick Answer

GUIDED THERAPEUTICS INC reported Cash And Cash Equivalents At Carrying Value of $2.31 million for the year ending 2022.

  • GUIDED THERAPEUTICS INC showed an increase of +259.7% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from GUIDED THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 30, 2023.
  • XBRL data for this metric is available from 2009 to 2022 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2009 to 2022), GUIDED THERAPEUTICS INC's Cash And Cash Equivalents At Carrying Value has grown by 905.7%.
  • Historical annual values: Fiscal year 2022: $2.31 million | Fiscal year 2021: $643.0 thousand | Fiscal year 2020: $182.0 thousand | Fiscal year 2019: $899.0 thousand | Fiscal year 2018: $0.00 | Fiscal year 2017: $1.0 thousand | Fiscal year 2016: $14.0 thousand | Fiscal year 2015: $35.0 thousand | Fiscal year 2014: $162.0 thousand | Fiscal year 2013: $613.0 thousand | Fiscal year 2012: $1.05 million | Fiscal year 2011: $2.20 million | Fiscal year 2010: $3.27 million | Fiscal year 2009: $230.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: